Open AccessCorrelation and Comparison of Somatostatin Receptor Type 2 Immunohistochemical Scoring Systems with <sup>68</sup>Ga-DOTATATE Positron Emission Tomography/Computed Tomography Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms
Author(s) -
Jiangyuan Yu,
Fang Cao,
Xinghui Zhao,
Qing Xie,
Ming Lu,
Jie Li,
Zhi Yang,
Yu Sun
Publication year - 2021
Publication title -
neuroendocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.493
H-Index - 101
eISSN - 1423-0194
pISSN - 0028-3835
DOI - 10.1159/000517530
Subject(s) - somatostatin receptor , somatostatin receptor 2 , positron emission tomography , neuroendocrine tumors , medicine , nuclear medicine , standardized uptake value , spearman's rank correlation coefficient , magnetic resonance imaging , concordance , rank correlation , correlation , immunohistochemistry , pathology , somatostatin , radiology , mathematics , statistics , geometry
Introduction: The overexpression of somatostatin receptor type 2 (SSTR2) is a unique characteristic of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs), which establishes the basis for both diagnosis and therapy. The SSTR status can be evaluated by immunohistochemical staining (IHC) and 68 Ga-DOTATATE positron emission tomography/computed tomography (PET/CT) imaging. This study attempted to determine the relationship between IHC and 68 Ga-DOTATATE PET/CT imaging and to explore the optimal cutoff value for SSTR IHC reading. Patients and Methods: A total of 100 GEP-NENs with SSTR PET/CT and pathological data were retrospectively analyzed, which consisted of neuroendocrine tumor (NET) G1 ( n = 9), NET G2 ( n = 64), NET G3 ( n = 13), neuroendocrine carcinoma ( n = 10), and mixed neuroendocrine-non-NENs ( n = 4). SSTR2-IHC results were interpreted by 4 well-established semiquantitative scoring systems, including human epidermal growth factor receptor 2 (HER2) score, Volante score, H score, and immunoreactive score. Results: In the homogeneous SSTR2 expression group (accounting for 57% of all cases), the 4 scoring systems were highly concordant with each other (Kendall’s Tau-b coefficient range: 0.80–0.96, p < 0.001) and also highly correlated with the 68 Ga-DOTATATE PET/CT imaging results (Spearman’s rank correlation coefficients: 0.71, 0.86, 0.80, and 0.71, p < 0.001). In the heterogeneous group (43%), the 4 scoring systems revealed a lower level of concordance (the Kendall Tau-b coefficient range: 0.40–0.75, p < 0.01), and the correlation with 68 Ga-DOTATATE PET/CT imaging was also lower, albeit statistically significant (Spearman’s rank correlation coefficients: 0.53, 0.38, 0.36, and 0.33, p < 0.05). Heterogeneous SSTR2 expression was mainly observed in the HER2 2+ cases, for which the combination with H score could help identify positive cases with increased sensitivity and specificity. The highest sensitivity and specificity of H scores in predicting the imaging results were achieved at 86.10 and 89.30% when defining the cutoff value as 160, indicating that 80% of the tumor cells were moderately positive or 55% were strongly positive. Conclusions: SSTR2 IHC was found to predict 68 Ga-DOTATATE PET/CT imaging accurately, especially in the homogeneous expression group. According to the positive 68 Ga-DOTATATE PET/CT outcomes, 80% of the tumor cells moderately positive or 55% strongly positive was the cutoff values for SSTR2-IHC reading.